Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2026-04-23 @ 5:24 AM
Study NCT ID:
NCT02922218
Status:
UNKNOWN
Last Update Posted:
2020-01-27
First Post:
2016-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.
Sponsor:
Centro Nacional de Investigaciones Oncologicas CARLOS III
Organization: